Why the study?
Current evidence on heart rate variability as a biomarker for acute brain injury in hypoxic ischemic encephalopathy is heterogeneous and required systematic review to evaluate its association with disease severity.
Is heart rate variability associated with the severity of hypoxic ischemic encephalopathy in neonates?
Is heart rate variability associated with the severity of hypoxic ischemic encephalopathy in neonates?
Moderate and severe hypoxic ischemic encephalopathy in neonates is associated with reduced heart rate variability during the first week of life, suggesting HRV as a potential biomarker for HIE severity.
May aid HIE severity stratification in neonates; supports HRV as biomarker but leaves clinical adoption open.
BACKGROUND: Several studies have investigated heart rate variability (HRV) as a biomarker for acute brain injury in hypoxic ischemic encephalopathy (HIE). However, the current evidence is heterogeneous and needs further reviewing to direct future studies. We aimed to systematically review whether HIE severity is associated with HRV. METHODS: This systematic review was conducted according to the preferred reporting items for systematic review and meta analyses (PRISMA). We included studies comparing neonates with severe or moderate HIE with neonates with mild or no HIE with respect to different HRV measures within 7 days of birth. Article selection and quality assessment was independently performed by two reviewers. Risk of bias and strength of evidence was evaluated by the Newcastle-Ottawa scale (NOS) and the Grading of Recommendations Assessment, Development and Evaluation (GRADE). RESULTS: We screened 1187 studies. From these, four observational studies with 248 neonates were included. For all HRV measures, the strength of evidence was very low. Neonates with severe or moderate HIE showed a reduction in most HRV measures compared to neonates with mild or no HIE with a greater reduction in those with severe HIE. CONCLUSIONS: Moderate and severe HIE was associated with a reduction in most HRV measures. Accordingly, HRV is a potential biomarker for HIE severity during the first week of life. However, the uncertainty calls for more studies.
No takes yet. Share an insight, caveat, or question.
Andersen et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: